The role certain blood lipid components have in the development of fatty liver disease (FLD) has been hypothesized but not confirmed. Researchers studied whether there was a correlation between remnant lipoprotein cholesterol (RLP-C) and occurrence of FLD.
Researchers sought to investigate the association between sleep-disordered breathing and sleep-related hypoxia with SARS-CoV-2 infection and COVID-19 outcomes.
Investigators assessed the incidence and clinical characteristics of liver diseases among patients with inflammatory bowel disease.
Researchers assessed the impact of inflammatory bowel disease on the perception of sleep quality.
A common complication in people with inflammatory bowel disease is bone disorders, including osteoporosis and osteopenia, regardless of the person’s age. Researchers in Bucharest looked at ways to access bone impairment in people with inflammatory bowel disease through diagnostic testing.
People with diabetes are at a higher risk of experiencing poor outcomes after contracting COVID-19, including hospitalization and death. Researchers expanded on a previous analysis to identify risk factors for short-term adverse outcomes among veterans with diabetes and COVID-19.
Investigators conducted a review to assess the role of glucagon-like peptide-1 receptor agonists in the treatment of NAFLD and NASH.
Investigators examined differences in the microbiomes of patients with colorectal neoplasia.
Researchers assessed the safety and efficacy of long-term treatment with givosiran in patients with acute hepatic porphyria.
Researchers evaluated the safety and efficacy of the investigational, microbiota-based, live biotherapeutic RBX2660 for treatment of recurrent C difficile infection.
